Cannabis stock Tilray ($TSE:TLRY) is making moves worldwide, and one of its latest comes from its subsidiary, Tilray Medical.
Tilray Brands agreed to acquire from DDH a promissory note for $23.8 million payable by 1974568 Ontario Limited.
Tilray Brands, Inc. TLRY has concluded the acquisition of Atwater Brewery from Molson Coors Beverage Company TAP. This marks ...
Tilray's FY24 growth was driven by M&A, with organic growth lagging and adjusted gross margins declining. See why I remain ...
Tilray Brand's Tilray Medical announced the launch of Redecan EU-GMP certified medical cannabis products in Australia.
Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “The launch of Redecan, a premium cannabis brand, in Australia is another significant milestone for Tilray ...
Tilray generates 25% of its revenue from beverage alcohol, 35% from cannabis, 33% from its distribution business and 7% from ...